KERYX
Live / Registered — Registered and renewed (as of 07 Nov 2025)
What this means for you
Registered since 27 Oct 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Oct 2025).
Record
- Serial number
- 86569190
- Registration number
- 4841166
- Mark type
- Stylized text
- Filed
- 19 Mar 2015
- Published for opposition
- 11 Aug 2015
- Registered
- 27 Oct 2015
- Next maintenance due
- 27 Oct 2025
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Prescription pharmaceutical and medicinal preparations for the treatment and prevention of kidney diseases and disorders, administered in any way other than topically
Owner
- Keryx Biopharmaceuticals, Inc., Cambridge, MA, US
- Keryx Biopharmaceuticals, Inc., New York, NY, US
- Keryx Biopharmaceuticals, Inc., New York, NY, US
Prosecution history
- 07 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 Nov 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 07 Nov 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 07 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 28 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Apr 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Oct 2021 — TEAS SECTION 8 & 15 RECEIVED
- 27 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Aug 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED